EFNS guidelines for the diagnosis and management of Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Neurology

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1468-1331.2010.03040.xPMID 20831773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2012cited by this paper
• Negative Functional Connectivity and Its Dependence on the Shortest Path Length of Positive Network in the Resting-State Human Brain

  2011cited by this paper
• Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

  2011cited by this paper
• Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe

  2010cited by this paper
• Imaging in Alzheimer's disease

  2009cited by this paper
• Statins for the prevention of dementia.

  2009cited by this paper
• Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT.

  2009cited by this paper
• Fluorodeoxyglucose-Positron Emission Tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study

  2009cited by this paper
• Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.

  2009cited by this paper
• Rivastigmine for Alzheimer's disease.

  2009cited by this paper
• Evidence-Based Evaluation of Diagnostic Accuracy of Resting EEG in Dementia and Mild Cognitive Impairment

  2009cited by this paper
• Ginkgo biloba for cognitive impairment and dementia.

  2009cited by this paper
• A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

  2009cited by this paper
• Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

  2009cited by this paper
• Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

  2009cited by this paper
• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  2009cited by this paper
• A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression.

  2008cited by this paper
• Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease

  2008cited by this paper
• Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

  2008cited by this paper
• Associations between Patterns of EEG Abnormalities and Diagnosis in a Large Memory Clinic Cohort

  2008cited by this paper
• Vitamin E for Alzheimer's disease and mild cognitive impairment.

  2008influential reference
• Amyloid-beta immunisation for Alzheimer's disease.

  2008cited by this paper
• THERMOREGULATION: RECENT CONCEPTS AND REMAINING QUESTIONS

  2008cited by this paper
• Reaction to a Dementia Diagnosis in Individuals with Alzheimer's Disease and Mild Cognitive Impairment

  2008cited by this paper
• Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

  2008cited by this paper
• Molecular genetics of Alzheimer's disease: An update

  2008cited by this paper
• Detecting dementia with the mini-mental state examination in highly educated individuals.

  2008cited by this paper
• Naming of objects, faces and buildings in mild cognitive impairment.

  2008cited by this paper
• Ginkgo biloba for prevention of dementia: a randomized controlled trial.

  2008cited by this paper
• Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study

  2008cited by this paper
• A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement

  2008cited by this paper
• Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.

  2008cited by this paper
• Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

  2008cited by this paper
• Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.

  2008cited by this paper
• Neuropsychiatric Manifestations in Mild Cognitive Impairment: A Systematic Review of the Literature

  2007cited by this paper
• Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer’s disease

  2007cited by this paper
• Antipsychotic Drug Use and Mortality in Older Adults with Dementia

  2007cited by this paper
• The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trials

  2007cited by this paper
• Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study

  2007cited by this paper
• Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features

  2007cited by this paper
• Neurology®

  2007cited by this paper
• Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials

  2007cited by this paper
• Consistency of Neuropsychiatric Syndromes across Dementias: Results from the European Alzheimer Disease Consortium

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• Donepezil for the treatment of agitation in Alzheimer's disease.

  2007cited by this paper
• Assessment of Behavioural and Psychological Symptoms Associated with Dementia

  2007cited by this paper
• Predictive testing for Huntington's disease.

  2007cited by this paper
• Amnestic syndrome of the medial temporal type identifies prodromal AD

  2007cited by this paper
• Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline

  2007influential reference
• Donepezil preserves cognition and global function in patients with severe Alzheimer disease

  2007cited by this paper
• Ginkgo biloba for cognitive impairment and dementia.

  2007cited by this paper
• The Category Cued Recall test in very mild Alzheimer's disease: discriminative validity and correlation with semantic memory functions

  2007cited by this paper
• Safety and tolerability of once‐daily versus twice‐daily memantine: a randomised, double‐blind study in moderate to severe Alzheimer's disease

  2007cited by this paper
• FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

  2007cited by this paper
• Sensitivity and Specificity of the Mini‐Mental State Examination for Identifying Dementia in the Oldest‐Old: The 90+ Study

  2007cited by this paper
• Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.

  2007cited by this paper
• Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study

  2006cited by this paper
• Declarative memory impairments in Alzheimer's disease and semantic dementia

  2006cited by this paper
• Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology

  2006cited by this paper
• Donepezil for dementia due to Alzheimer's disease.

  2006cited by this paper
• Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects.

  2006cited by this paper
• The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening

  2006cited by this paper
• Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease

  2006cited by this paper
• CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease

  2006cited by this paper
• Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

  2005cited by this paper
• Brain biopsy in dementia.

  2005cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• The AD8

  2005cited by this paper
• An fMRI study of the Trail Making Test.

  2005cited by this paper
• Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.

  2005cited by this paper
• PET imaging in the assessment of normal and impaired cognitive function.

  2005cited by this paper
• Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer’s disease

  2005cited by this paper
• A total score for the CERAD neuropsychological battery

  2005cited by this paper
• Detecting depression in Alzheimer's disease: evaluation of four different scales.

  2005cited by this paper
• The search for disease modification in moderate to severe Alzheimer disease

  2005cited by this paper
• Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004 *

  2004cited by this paper
• The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia

  2004cited by this paper
• Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

  2004cited by this paper
• Piracetam for dementia or cognitive impairment.

  2004cited by this paper
• A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.

  2004cited by this paper
• Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

  2004cited by this paper
• Visual memory predicts Alzheimer’s disease more than a decade before diagnosis

  2003cited by this paper
• CSF markers for incipient Alzheimer's disease.

  2003cited by this paper
• Selegiline for Alzheimer's disease.

  2003cited by this paper
• Ecological implications of ideomotor apraxia

  2003cited by this paper
• Ecological implications of ideomotor apraxia: Evidence from physical activities of daily living

  2003influential reference
• Attitudes of Patients With Mild Dementia and Their Carers Towards Disclosure of the Diagnosis

  2003cited by this paper
• Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.

  2002cited by this paper
• Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals

  2002cited by this paper
• Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease

  2002cited by this paper
• ["The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease].

  2002cited by this paper
• Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype

  2002cited by this paper
• Prevalence and impact of medical comorbidity in Alzheimer's disease.

  2002cited by this paper
• Executive dysfunction in subcortical ischaemic vascular disease

  2002cited by this paper
• Presenilin-interacting proteins

  2002cited by this paper
• Antidepressants for treating depression in dementia.

  2002cited by this paper
• SPECT perfusion imaging in the diagnosis of Alzheimer’s disease

  2001influential reference
• Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease

  2001cited by this paper

• Extraction and interpretation of EEG features for diagnosis and severity prediction of Alzheimer's Disease and Frontotemporal dementia using deep learning

  2026cites this paper
• Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer's disease in an ethnically mixed cohort.

  2026cites this paper
• Biomarkers for Alzheimer's disease across diverse biological domains: An umbrella review and evidence map.

  2025cites this paper
• Reducing inference cost of Alzheimer’s disease identification using an uncertainty-aware ensemble of uni-modal and multi-modal learners

  2025cites this paper
• A Multimodal Multi-Stage Deep Learning Model for the Diagnosis of Alzheimer’s Disease Using EEG Measurements

  2025cites this paper
• What do European clinical guidelines say about genetic testing for people with neuropsychiatric disorders? A scoping review

  2025cites this paper
• Dementia Burden, Prevention, Intervention and Care in Jordan

  2025cites this paper
• Causal relationship between Alzheimer’s disease and obstructive sleep apnoea: Insights from a biomechanics-oriented bidirectional mendelian randomization study

  2025influential citation
• Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

  2025cites this paper
• The relationship between choroid plexus volume, DTI-ALPS index, kidney function, and amyloid pathology in alzheimer’s disease

  2025cites this paper
• Exosomal miRNA biomarkers in Alzheimer's disease: Systematic review and meta-analysis.

  2025cites this paper
• Efficacy and cost‐effectiveness of extended nursing roles in dementia care: Results of the cluster‐randomized trial InDePendent

  2025cites this paper
• [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

  2025cites this paper
• AI-based staging, causal hypothesis and progression of subjects at risk of Alzheimer’s disease: a multicenter study

  2025cites this paper
• Predicting Alzheimer’s Disease Progression from Sparse Multimodal Data by NeuralODE Models

  2025influential citation
• European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders.

  2024cites this paper
• The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD‐ADRD): Validated clinical assessment instruments

  2024cites this paper
• A Review on Machine Learning Approaches for Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment Based on Brain MRI

  2024cites this paper
• Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care

  2024cites this paper
• Use of Modern Classification Systems for the Complex Diagnostics of Alzheimer’s Disease

  2024cites this paper
• Systemic determinants of brain health in ageing

  2024cites this paper
• Brain Stimulation in Alzheimer’s Disease Trials

  2024cites this paper
• [Use of modern classification systems for complex diagnostics of Alzheimer's disease].

  2024cites this paper
• The relationship between atherosclerosis and dementia.

  2024cites this paper
• Brain perfusion SPECT in dementia: what radiologists should know

  2024cites this paper
• The Effects of Prospective Memory Intervention on Language Ability and Activities of Daily Living in the Elderly with Alzheimer’s Disease

  2024cites this paper
• Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data

  2024cites this paper
• Do clinical guidelines support person-centred care for women affected by dementia: A content analysis

  2024cites this paper
• Adolopment of clinical practice guidelines and creation of referral pathways for psychiatric conditions in Pakistan

  2024cites this paper
• Olfaction and thyroid hormones in patients with subjective cognitive decline, non-amnestic and amnestic mild cognitive impairment

  2024cites this paper
• PET/CT/MRI in Clinical Trials of Alzheimer’s Disease

  2024cites this paper
• Exploring research hotspots and emerging trends in neuroimaging of vascular cognitive impairment: a bibliometric and visualized analysis

  2024cites this paper
• A task force for diagnosis and treatment of people with Alzheimer’s disease in Latin America

  2023cites this paper
• Validation of automated hippocampus volume assessment using deep learning convolutional neural networks in patients with Alzheimer's disease

  2023cites this paper
• Clinical profile and survival analysis of Alzheimer’s disease patients in a Brazilian cohort

  2023cites this paper
• Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?

  2023cites this paper
• The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease.

  2023cites this paper
• Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging

  2023cites this paper
• The ambivalence toward neuropsychology in dementia research, diagnosis, and drug development: Myths and misconceptions

  2023cites this paper
• Development and validation of a nomogram-assisted tool to predict potentially reversible cognitive frailty in Chinese community-living older adults.

  2023cites this paper
• A Real-Time Neurophysiologic Stress Test for the Aging Brain: Novel Perioperative and ICU Applications of EEG in Older Surgical Patients

  2023cites this paper
• Association between Incidence of Prescriptions for Alzheimer’s Disease and Beta-Adrenoceptor Antagonists: A Prescription Sequence Symmetry Analysis

  2023cites this paper
• Comparison of deep learning convolutional neural networks method with conventional volume-based morphometry measurement of hippocampal volume in Alzheimer's disease

  2023cites this paper
• Detection rate of contrast-enhanced brain magnetic resonance imaging in patients with cognitive impairment

  2023cites this paper
• In vivo Volumetric, DTI and 1H MRS Rat Brain Protocol for Monitoring Early Neurodegeneration and Efficacy of the Used Therapy

  2023cites this paper
• Factors influencing the help-seeking behavior in patients with mild cognitive impairment: a qualitative study

  2023cites this paper
• Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System

  2023cites this paper
• Cognitive Dysfunction and Affective Mood Disorder Screening in Patients With Chronic Inflammatory Bowel Disease: Protocol for a Prospective Case-Control Study

  2023cites this paper
• Predicted Cognitive Conversion in Guiding Early Decision-Tailoring on Patients With Cognitive Impairment

  2022cites this paper
• Diagnosis of Alzheimer’s disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

  2022cites this paper
• Prise en charge de la maladie d’Alzheimer et des maladies apparentées selon les recommandations de la Haute Autorité de santé française

  2022cites this paper
• Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease

  2022influential citation
• Pattern of structural magnetic resonance imaging lesions in the patients with progressive cognitive decline: A single-center study in Southeast Nigeria

  2022cites this paper
• Associations of fish oil supplementation with incident dementia: Evidence from the UK Biobank cohort study

  2022cites this paper
• Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.

  2022cites this paper
• The effectiveness of adaptive working memory training on EEG and cognitive performance in Alzheimer disease

  2022cites this paper
• Long-term use of pharmacological treatment in Alzheimer’s disease: a retrospective cohort study in real-world clinical practice

  2022cites this paper
• Fish Behavior as a Neural Proxy to Reveal Physiological States

  2022cites this paper
• Tasks and Activities of an Effective Collaborative Dementia Care Management Program in German Primary Care

  2022cites this paper
• Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment

  2022cites this paper
• Malnutrition is positively associated with cognitive decline in centenarians and oldest-old adults: A cross-sectional study

  2022cites this paper
• Diagnostic yield of diffusion-weighted brain MR imaging in patients with cognitive impairment: Large cohort study with 3,298 patients

  2022cites this paper
• Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer disease: A protocol of a randomized controlled trial

  2022cites this paper
• CURVED MULTIFORMAT IMAGING OF STRUCTURAL MRI AS A BIOMARKER FOR PROFILING OF VARIOUS DEMENTIA - AN ALGORITHMIC APPROACH WITH MR/PET.

  2022cites this paper
• Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia

  2022cites this paper
• Mechanism of Neural Regeneration Induced by Natural Product LY01 in the 5×FAD Mouse Model of Alzheimer’s Disease

  2022cites this paper
• [Team players or lone fighters? Importance and utilization of practice staff in primary care dementia detection].

  2022cites this paper
• Time trends in psychotropic drug prescriptions in Dutch nursing home residents with dementia between 2003 and 2018

  2022cites this paper
• The role of cell division control protein 42 in tumor and non-tumor diseases: A systematic review

  2022cites this paper
• Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer’s dementia using OMOP CDM

  2022cites this paper
• Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria

  2022cites this paper
• Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.

  2022cites this paper
• Diagnosis of Alzheimer’s disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

  2022cites this paper
• Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy

  2022cites this paper
• Pathophysiology of Alzheimer's Disease.

  2022cites this paper
• Prionopathies and Prionlike Protein Aberrations in Neurodegenerative Diseases

  2021cites this paper
• Anti-dementia Medication

  2021cites this paper
• Deep learning from MRI-derived labels enables automatic brain tissue classification on human brain CT

  2021cites this paper
• Neuropsychological Testing

  2021cites this paper
• High Correlation of Static First-Minute-Frame (FMF) PET Imaging after 18F-Labeled Amyloid Tracer Injection with [18F]FDG PET Imaging

  2021cites this paper
• Transcranial Magnetic Stimulation as a Diagnostic and Therapeutic Tool in Various Types of Dementia

  2021cites this paper
• Emerging insights into the role of albumin with plasma exchange in Alzheimer's disease management.

  2021cites this paper
• Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease

  2021cites this paper
• Digital delivery of non-pharmacological intervention programmes for people living with dementia during the COVID-19 pandemic

  2021cites this paper
• Diagnosis of Alzheimer's Disease by Time-Dependent Power Spectrum Descriptors and Convolutional Neural Network Using EEG Signal

  2021cites this paper
• Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).

  2021cites this paper
• Semantic Memory as an Early Cognitive Marker of Alzheimer’s Disease: Role of Category and Phonological Verbal Fluency Tasks

  2021cites this paper
• Expanded Exploration of the Auditory Naming Test in Patients with Dementia

  2021cites this paper
• Deep Brain Stimulation in Alzheimer’s Disease: Targeting the Nucleus Basalis of Meynert

  2021cites this paper
• Increased risk for dementia in neurofibromatosis type 1

  2021cites this paper
• Celecoxib effect on rivastigmine anti-Alzheimer activity against aluminum chloride-induced neurobehavioral deficits as a rat model of Alzheimer's disease; novel perspectives for an old drug

  2021cites this paper
• Title : Genetic Testing for Alzheimer ’ s Disease

  2021cites this paper
• Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer’s Disease: A Multicenter, Prospective Cohort Study

  2021cites this paper
• Anti-Dementia Medications: Course and Duration of Therapy and Withdrawal Syndromes

  2021cites this paper
• Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study

  2021cites this paper
• Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.

  2021cites this paper
• Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling

  2021cites this paper
• Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients

  2021cites this paper
• Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management

  2021cites this paper
• Global trends in symptomatic medication use against dementia in 66 countries/regions from 2008 to 2018

  2021cites this paper